Profiel
Daniel Richner is currently the Chairman & Chief Executive Officer at M+R Spedag Group AG since 2006.
Prior to this, he worked as an Investment Advisor at HBM Partners AG from 2004 to 2006.
He also held positions as a Director at Pevion Biotech AG, and as a Principal at HBM Healthcare Investments AG, NanoDimension AG, and Cantrade Privatbank AG.
Dr. Richner received his undergraduate, graduate, and doctorate degrees from the University of Basel.
Actieve functies van Daniel Richner
| Bedrijven | Functie | Begin |
|---|---|---|
M+R Spedag Group AG
M+R Spedag Group AG Air Freight/CouriersTransportation Provides transportation and logistics services | Algemeen Directeur | 01-01-2006 |
Eerdere bekende functies van Daniel Richner
| Bedrijven | Functie | Einde |
|---|---|---|
HBM Partners AG
HBM Partners AG Investment ManagersFinance HBM Partners invests in private and public companies located in India, China, North America and Europe. The firm focuses on biopharma, medtech, diagnostics and healthcare sectors. It provides financing for early, buyout and growth stage capital requirements with an investment size from USD 5 to 50 million. | Private Equity Investor | 08-02-2006 |
NanoDimension AG | Corporate Officer/Principal | - |
| HBM HEALTHCARE INVESTMENTS AG | Corporate Officer/Principal | - |
Cantrade Privatbank AG
Cantrade Privatbank AG Regional BanksFinance Operates as a private bank | Corporate Officer/Principal | - |
Pevion Biotech AG
Pevion Biotech AG Pharmaceuticals: MajorHealth Technology Develops efficient and safe vaccines based on proprietary technology | Directeur/Bestuurslid | - |
Opleiding van Daniel Richner
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
HBM Partners AG
HBM Partners AG Investment ManagersFinance HBM Partners invests in private and public companies located in India, China, North America and Europe. The firm focuses on biopharma, medtech, diagnostics and healthcare sectors. It provides financing for early, buyout and growth stage capital requirements with an investment size from USD 5 to 50 million. | Finance |
HBM Healthcare Investments AG
HBM Healthcare Investments AG Investment Trusts/Mutual FundsMiscellaneous Functions as a closed-end investment fund or Investment trust | Miscellaneous |
University of Basel
University of Basel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NanoDimension AG | |
M+R Spedag Group AG
M+R Spedag Group AG Air Freight/CouriersTransportation Provides transportation and logistics services | Transportation |
Pevion Biotech AG
Pevion Biotech AG Pharmaceuticals: MajorHealth Technology Develops efficient and safe vaccines based on proprietary technology | Health Technology |
Cantrade Privatbank AG
Cantrade Privatbank AG Regional BanksFinance Operates as a private bank | Finance |
















